- Table of Contents
- List of Tables
- List of Figures
- Global Chagas Disease (American Trypanosomiasis) Pipeline Overview
- Key Findings, 2019
- Disease Overview
- Report Guide and Research Methodology

- Executive Summary
- Chagas Disease (American Trypanosomiasis) Drugs under active development, H1- 2019
- Pipeline Drugs in Early Stage of Development (Pre-clinical, Discovery, Phase 1 and Phase 2)
- Pipeline Drugs in Advanced Stage of Development (Phase 3, Pre-registration)
- Companies involved in Chagas Disease (American Trypanosomiasis) pipeline, H1- 2019
- Mechanism of Action wise Chagas Disease (American Trypanosomiasis) Pipeline Candidates

- Astellas Pharma Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- AstraZeneca Plc Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Bayer AG Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Collaborations Pharmaceuticals Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Daiichi Sankyo Co Ltd Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Drugs for Neglected Diseases initiative Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Drugsfor Neglected Diseases initiative Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Eisai Co Ltd Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Evotec AG Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- GlaxoSmithKline Plc Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Janssen Pharmaceuticals  Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Kancera AB Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Novartis AG Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Oblita Therapeutics BVBA Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- RIKEN Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Sanofi Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Vyera Pharmaceuticals Chagas Disease (American Trypanosomiasis) Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments
- Latest Chagas Disease (American Trypanosomiasis) Drug Pipeline Developments, 2019

- Appendix
- About Us
- Sources and Methodology
- Contact Information